ESPR - Esperion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ESPR is currently covered by 7 analysts with an average price target of $14.65. This is a potential upside of $12.22 (502.88%) from yesterday's end of day stock price of $2.43.

Esperion Therapeutics's activity chart (see below) currently has 210 price targets and 195 ratings on display. The stock rating distribution of ESPR is 90.91% BUY, 6.06% HOLD and 3.03% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.98% with an average time for these price targets to be met of 123.82 days.

Highest price target for ESPR is $16, Lowest price target is $4, average price target is $5.75.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 17-Jun-2025. First documented stock forecast 27-Oct-2014.

Currently out of the existing stock ratings of ESPR, 30 are a BUY (90.91%), 2 are a HOLD (6.06%), 1 are a SELL (3.03%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$13.78 (620.72%)

$16

2 months 17 days ago
(17-Jun-2025)

0/6 (0%)

$14.91 (1367.89%)

Buy

$4

$1.78 (80.18%)

$5

3 months 27 days ago
(07-May-2025)

0/13 (0%)

$3.13 (359.77%)

Buy

$4

$1.78 (80.18%)

5 months 29 days ago
(05-Mar-2025)

1/12 (8.33%)

$2.35 (142.42%)

255

Buy

$4

$1.78 (80.18%)

$7

6 months 23 days ago
(11-Feb-2025)

0/3 (0%)

$2.21 (123.46%)

Hold

$4

$1.78 (80.18%)

$3.5

8 months 16 days ago
(18-Dec-2024)

8/9 (88.89%)

$1.84 (85.19%)

79

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ESPR (Esperion Therapeutics) average time for price targets to be met?

On average it took 123.82 days on average for the stock forecasts to be realized with a an average price target met ratio 39.98

Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?

JOEL BEATTY

Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?

Joel Beatty works at BAIRD and has 11 price targets and 8 ratings on ESPR

Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?

Alex Schwartz with highest potential upside - $91.78

Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?

Martin Auster with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?